APR 27, 2016 8:46 AM PDT

Autoimmune Encephalitis Mimics Effect of "Angel Dust"

WRITTEN BY: Kara Marker
Originally developed as an anesthetic in 1926, phencyclidine (PCP), also known as “angel dust,” was discontinued in 1965 when patients receiving the drug reported feeling delusional, anxious, and agitated. Soon after PCP emerged as an abused substance, and it is now present in many illegal drugs. Almost a century later, scientists discovered an autoimmune disease called autoimmune encephalitis (AE) which strangely has many of the same effects on the brain as PCP.
 
Like PCP, AE disrupts the function of a neurotransmitter called glutamate, specifically the NMDA receptor. A schedule II controlled substance, PCP causes feelings of detachment from the environment and self, while anti-NMDA AE produced schizophrenia-like symptoms: behavioral changes, psychosis, memory loss, and decreased levels of consciousness.
 
"Angel Dust"
 
In a new study published in Biological Psychiatry, scientific experts looked at AE patients recovering from the acute phase of the disease, testing their memory and looking for structural damage in the hippocampus, the part of the brain strongly associated with memory.
 
Multimodal magnetic resonance imaging (MRI) data from the 40 recovering AE patients showed several destruction of hippocampal microstructural integrity, as compared to 25 healthy control subjects. Decreased hippocampal volumes observed from the data was directly correlated to patients’ memory performance, severity of disease, and duration of disease.
 
Scientists and doctors agree that treating anti-NMDA AE quickly and aggressively is of utmost importance, because any behavioral symptoms that arise imply that autoantibodies are attacking hippocampal tissues. Unfortunately, the disease is incredibly difficult to diagnose.
 
MRI in Encephalitis. Areas of increased signal intensity are noted in the hippocampi. The right side is slightly thickened.
 
"[The behavioral symptoms] may be easily misdiagnosed as the psychiatric disorders that they superficially resemble,” explained Biological Psychiatry Editor Dr. John Krystal.
 
“Early and aggressive treatment of AE leads to the best outcomes,” experts from the Autoimmune Encephalitis Alliance (AEA) added.
 
Additionally, AE diagnosis requires “collaboration among multiple medical disciplines,” as described by the AEA, with neurologists, rheumatologists, psychiatrists, and immunologists among some of the professionals needed.
 
A few treatment options exist for fortunate patients who receive an early diagnosis of one of the 13 known types of AE:
  • Removal of teratoma (if present) that could be triggering autoimmune response
  • Anti-inflammatory drugs
  • Plasmapheresis to remove autoantibodies
  • Intravenous immunoglobulin – occupies binding sites so harmful antibodies cannot attack brain tissue
Increased understanding of the disease progression from this study is also encouraging scientists to find more ways to better diagnose AE as early as possible, with advanced imagine protocols the first technology scientists plan to explore.
 
 
Source: Elsevier, Autoimmune Encephalitis Alliance,  Center for Substance Abuse Research at the University of Maryland
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 23, 2019
Immunology
OCT 23, 2019
Treating Celiac Disease May Be Possible
Delivering gluten to the body in a friendly, harmless package may be the way for people with celiac disease to finally have a sandwich again. A new clinica...
OCT 29, 2019
Microbiology
OCT 29, 2019
Antibody Discovered That May be the Key to a Universal Flu Vaccine
Instead of designing a new flu vaccine every year, researchers have made a breakthrough that may lead to a single vaccine that protects against all strains....
NOV 22, 2019
Immunology
NOV 22, 2019
Rogue Inflammation Activates Depression During Pregnancy
Unresolved inflammation in a pregnant woman’s body can lead to serious depression during and after pregnancy. A new study investigates the physiologi...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug To Treat Ulcerative Colitis
Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmu...
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently infected. Having made top news storie...
Loading Comments...